BRIEF RESEARCH REPORT article
Front. Genet.
Sec. Cancer Genetics and Oncogenomics
Volume 16 - 2025 | doi: 10.3389/fgene.2025.1667899
This article is part of the Research TopicUnraveling Germline Mutations: Advances in Genetic Profiling for Cancer RiskView all 5 articles
A Rare Subtype of Lynch Syndrome Familial with Co-mutation of EpCAM c.344T>C, MSH2 c.2744A>G, PMS2 c.1408C>T and APC c.5465T>A, Case Report and Literature Review
Provisionally accepted- 1The Fourth People's Hospital of Zigong City, Zigong, China
- 2Yunnan Cancer Hospital, Kunming, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Lynch syndrome (LS) is an autosomal dominant disorder caused by germline mutations in mismatch repair (MMR) genes or EpCAM, leading to various cancers, particularly colorectal cancer (CRC). EpCAM mutations account for approximately 1-3% of LS cases, while co-mutations involving EpCAM and MSH2 are exceedingly rare. To date, co-mutations of EpCAM, MSH2 and PMS2 have not been reported in the literature. Case Presentation: This case reports a 25-year-old male diagnosed with adenocarcinoma of the ascending colon. His family history revealed eight cancer cases among 30 relatives across five generations, consistent with LS. Immunohistochemistry (IHC) of the tumor showed loss of EpCAM, MSH2 and MSH6 protein expression. Genetic testing of the proband's tumor identified a novel large deletion affecting EpCAM exons 8-9 and MSH2 exons 1-16, likely pathogenic mutations disrupting MMR gene function. Whole-exome sequencing (WES) of peripheral blood from six family members, including the proband and his son, revealed co-mutations of EpCAM (c.344T>C), MSH2 (c.2744A>G), PMS2 (c.1408 C>T) and APC (c.5465T>A). Although public databases suggested these variants are benign or of uncertain significance (VUS), several in silico prediction tools and prior literature suggest potential pathogenicity. Notably, WES of the proband's son's peripheral blood also detected the same large deletions in EpCAM and MSH2, implying the presence of germline mosaicism and a possibly heightened early-onset cancer risk. Conclusion: This rare subtype of LS emphasizes the need for comprehensive genetic screening and may inform future strategies for early detection and management in LS families. Further studies are required to confirm these findings.
Keywords: Lynch Syndrome, EpCAM, MSH2, PMS2, APC, Co-mutation, Mosaicism, case report
Received: 17 Jul 2025; Accepted: 03 Oct 2025.
Copyright: © 2025 Lu, Pan, Deng, Wan, Wang, Hu, Dong and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xian shuo Cheng, chengxianshuo@sina.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.